Novotny J R, Rosenthal C, Elmaagacli A H, Dürig J, Beelen D W, Dührsen U
Department of Haematology, University of Essen, Essen, Germany.
Eur J Haematol. 2004 Jul;73(1):1-9. doi: 10.1111/j.1600-0609.2004.00255.x.
To test whether the functional impairment of the host bone marrow (BM) microenvironment pre-existing at the time of transplantation could be overcome by the increased content of immature cells in allogeneic peripheral blood stem cell transplantation (PBSCT) when compared with bone marrow transplantation (BMT).
Cobble stone area forming cells (CAFC) were assayed in normal BM and BM after allogeneic BMT and PBSCT after stable engraftment. Groups were compared by two-tailed t-test.
While BM from 11 normal controls contained an average of 778.8 CAFC-d35 per 10(6) low density bone marrow cells (LDBMC, range 453-1231 per 10(6) LDBMC), BM from patients after BMT contained an average of 123.7 CAFC-d35 per 10(6) LDBMC (range 38-257) per 10(6) LDBMC. BM from patients transplanted with PBSC after myeloablative conditioning contained 128.3 (range 46-305) CAFC-d35 per 10(6) LDBMC (P = 0.89 compared with BMT). Similar results were obtained when patients after PBSCT with non-myeloablative conditioning were included (P = 0.62 compared with BMT). CAFC numbers in patients transplanted in early stages of myeloid leukaemia (acute myeloid leukaemia first remission, chronic myeloid leukaemia first chronic phase) were significantly higher than CAFC numbers in patients transplanted in more advanced stages (P = 0.008) or myelodysplastic syndrome (P = 0.023). The lowest CAFC numbers were found in two cases of retransplantation.
Our findings indicate that the functional state of the BM microenvironment rather than stem cell dose or source is limiting for the homing and engraftment of immature haemopoietic cells in clinical transplantation.
检测在移植时预先存在的宿主骨髓(BM)微环境功能损伤,与骨髓移植(BMT)相比,在异基因外周血干细胞移植(PBSCT)中增加的未成熟细胞含量是否能够克服该损伤。
在正常骨髓以及异基因BMT和稳定植入后的PBSCT后的骨髓中检测鹅卵石区域形成细胞(CAFC)。通过双尾t检验比较各组。
11名正常对照者的骨髓每10⁶低密度骨髓细胞(LDBMC)平均含有778.8个CAFC-d35(范围为每10⁶LDBMC 453 - 1231个),BMT后患者的骨髓每10⁶LDBMC平均含有123.7个CAFC-d35(范围为38 - 257个)。清髓性预处理后接受PBSC移植患者的骨髓每10⁶LDBMC含有128.3个(范围为46 - 305个)CAFC-d35(与BMT相比,P = 0.89)。纳入非清髓性预处理的PBSCT患者后也得到了类似结果(与BMT相比,P = 0.62)。髓系白血病早期(急性髓系白血病首次缓解期、慢性髓系白血病首次慢性期)移植患者的CAFC数量显著高于更晚期移植患者(P = 0.008)或骨髓增生异常综合征患者(P = 0.023)。在两例再次移植病例中发现CAFC数量最低。
我们的研究结果表明,在临床移植中,骨髓微环境的功能状态而非干细胞剂量或来源对未成熟造血细胞的归巢和植入具有限制作用。